Pharma Tech Outlook: Accelerating The Discovery of Novel Therapeutic Candidates
Read More
High Throughput Antibody Discovery: 100x the Data in 10% of the Time
Read More
Carterra’s 2022 Halloween Party
Read More
Increasing DNA Encoded Library (DEL) Screening Resolution Using HT-SPR
Read More
Ernst and Young Selects Josh Eckman, CEO of Carterra, as 2022 Entrepreneur of the Year Mountain West Award Winner
Read More
Broadly neutralizing antibodies target the coronavirus fusion peptide
Read More
La Jolla Institute for Immunology Acquires LSA Platform
Read More
Carterra Joins the Tetra Partner Network to Advance Therapeutics Discovery
Read More
University of Manchester Adds Carterra’s LSA Instrument for High-Throughput Antibody Screening and Characterization
Read More
Carterra celebrates the 100th LSA shipped
Read More
